Captor Therapeutics SA
WSE:CTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Captor Therapeutics SA
WSE:CTX
|
PL |
|
B
|
Beyond Inc
XMUN:OVER
|
US |
|
C
|
Coffee Holding Co Inc
XBER:E6U
|
US |
|
A
|
Ameren Corp
LSE:0HE2
|
US |
|
Peugeot Invest SA
OTC:SFFFF
|
FR |
|
Mitek Systems Inc
NASDAQ:MITK
|
US |
|
Sivers Semiconductors AB
OTC:SIVEF
|
SE |
|
K
|
Kforce Inc
XMUN:ROF
|
US |
|
R
|
Rheinmetall AG
DUS:RHM
|
DE |
|
A
|
Alaska Air Group Inc
SWB:ALK
|
US |
|
S
|
Sixt SE
XBER:SIX2
|
DE |
|
S
|
Southwestern Energy Co
XBER:SW5
|
US |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
A
|
Allcore SpA
MIL:CORE
|
IT |
|
B
|
Befesa SA
DUS:BFSA
|
LU |
Wall St Price Targets
CTX Price Targets Summary
Captor Therapeutics SA
According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CTX's stock price target?
Price Target
68.34
PLN
According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.
What is the Revenue forecast for Captor Therapeutics SA?
Projected CAGR
204%
The compound annual growth rate for Revenue over the next 3 years is 204%.
What is the Gross Profit forecast for Captor Therapeutics SA?
Projected CAGR
77%
The compound annual growth rate for Gross Profit over the next 2 years is 77%.
